| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/23/1994 | EP0587799A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 03/23/1994 | EP0587751A1 Therapeutic compositions for osteoinduction |
| 03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587698A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
| 03/23/1994 | EP0587571A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 03/23/1994 | EP0504236B1 Utilisation of extracts of algae for the preparation of pharmaceutical, cosmetic, food or agricultural compositions |
| 03/23/1994 | EP0433360B1 Improvements relating to the production of prodrugs |
| 03/22/1994 | US5296591 Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
| 03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
| 03/22/1994 | US5296505 Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium |
| 03/22/1994 | US5296496 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 03/22/1994 | US5296494 Pyrrolidine compounds having thromboxane A2 receptor antagonistic activity and thromboxane A2 synthase inhibiting activity |
| 03/22/1994 | US5296481 Treatment process for promoting weight loss employing a substituted Δ5 |
| 03/22/1994 | US5296246 Active amino acid Ca, beverages containing same, and process for their production |
| 03/22/1994 | US5296243 Including in feed sugars, sugar alcohols, amino acids or amides to produce lectins which attach to agarose in neutral buffer, dissociate after addition of methyl glucoside |
| 03/22/1994 | CA1327936C Phospholipase a_ inhibiting compositions and their use |
| 03/18/1994 | EP0573565A4 Opiate receptor antagonist modulates hyperkinetic movement disorder. |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005786A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
| 03/17/1994 | WO1994005785A1 Multicistronic expression units and their use |
| 03/17/1994 | WO1994005674A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
| 03/17/1994 | WO1994005671A1 Fullerene derivatives, method of synthesizing them and their use |
| 03/17/1994 | WO1994005661A1 Pyridopyrimidinone antianginal agents |
| 03/17/1994 | WO1994005654A1 Heteroaryl compounds used as pharmaceuticals |
| 03/17/1994 | WO1994005634A1 Benzo-fused lactams promote release of growth hormone |
| 03/17/1994 | WO1994005631A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
| 03/17/1994 | WO1994005531A1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
| 03/17/1994 | WO1994005318A1 Method of treating cell damage or depletion |
| 03/17/1994 | WO1994005317A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | WO1994005316A1 Products and methods for improving keratinocyte adhesion to the dermis |
| 03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | WO1994005299A1 Medicinal composition |
| 03/17/1994 | WO1994005297A1 Drugs containing diphosphonic acids and salts thereof |
| 03/17/1994 | WO1994005296A2 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 03/17/1994 | WO1994005289A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 03/17/1994 | WO1994005275A1 Method of preventing nmda receptor-mediated neuronal damage |
| 03/17/1994 | WO1994005274A1 Glycation inhibitor |
| 03/17/1994 | WO1994005270A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass |
| 03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 03/17/1994 | EP0585366A4 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood. |
| 03/17/1994 | CA2144423A1 Heteroaryl compounds used as pharmaceuticals |
| 03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | CA2144051A1 New fullerene derivatives, method of synthesizing them and their use |
| 03/17/1994 | CA2143653A1 Methods for treating renin-related disorders with amylin antagonists |
| 03/17/1994 | CA2143644A1 Products and methods for improving keratinocyte adhesion to the dermis |
| 03/17/1994 | CA2141965A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
| 03/17/1994 | CA2141425A1 Nitrogen substituted acridine and cytochrome p450 inhibitors and methods of use |
| 03/17/1994 | CA2122342A1 Pharmaceutical composition |
| 03/16/1994 | EP0587499A1 Benzopyran compounds, process for their preparation and their use as cell protectors |
| 03/16/1994 | EP0587378A1 Prevention of bone resorption |
| 03/16/1994 | EP0587134A2 Cyclic urea derivatives, medicaments containing them and process for their preparation |
| 03/16/1994 | EP0587087A1 Substituted cyclohexane derivatives for the treatment of diseases |
| 03/16/1994 | EP0587055A1 Use of manganese superoxide dismutase (Mn-SOD) in low dosage for the production of pharmaca for the treatment of diseases |
| 03/16/1994 | EP0586960A1 Xanthone derivatives, their preparation and use |
| 03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
| 03/16/1994 | EP0586608A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586549A1 Selecting ligand agonists and antagonists |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586525A1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives. |
| 03/16/1994 | EP0586523A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/16/1994 | EP0586490A1 Novel derivatives of perhydroisoindol, their preparation, and pharmaceutical compositions containing them. |
| 03/16/1994 | EP0586479A1 Dihydroxyindanone tyrosine kinase inhibitors |
| 03/16/1994 | EP0586474A1 Peptide nucleic acids |
| 03/16/1994 | EP0586466A1 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same |
| 03/16/1994 | EP0455789B1 Method of preventing or limiting reperfusion damage |
| 03/16/1994 | EP0445206B1 Hydroxamic acid based collagenase inhibitors |
| 03/16/1994 | EP0391971B1 Improving toxicity profiles in chemotherapy |
| 03/16/1994 | EP0368912B1 Polyanhydrides with improved hydrolytic degradation properties |
| 03/16/1994 | CN1083812A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/16/1994 | CN1083703A Pharmaceutical composition with functions of antialcohol, promoting change of energy, of mucosa of stomach, acidification, secretion, antradiation and anticholera |
| 03/15/1994 | US5294724 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters and a process for their preparation |
| 03/15/1994 | US5294716 Multistage cleavage of phenyl with base |
| 03/15/1994 | US5294634 Osteogenesis promoter |
| 03/15/1994 | US5294632 Diuretics and vasorelaxants |
| 03/15/1994 | US5294631 Substituted benzimidazoles useful as angiotension II receptor antagonists |
| 03/15/1994 | US5294626 Arylsulphonamides pharmaceutical compositions containing these compounds |
| 03/15/1994 | US5294623 (Benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma |
| 03/15/1994 | US5294620 Hypotensive agents or compounds for cardiovascular disorders |
| 03/15/1994 | US5294619 Arylpiperidine derivatives |
| 03/15/1994 | US5294538 Enzyme inhibitor |
| 03/15/1994 | CA1327805C Pilocarpine derivatives |
| 03/15/1994 | CA1327803C Derivatives of 1,2,5,6-tetrahydropyridin-3- carboxaldehyde oxime, their preparation process, their use as medicaments, and the compositions containing them |
| 03/15/1994 | CA1327800C Derivatives of aza-2-bicyclooctane-3-carboxylic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/15/1994 | CA1327795C Antidepressants which are aryloxy inadanamines |
| 03/15/1994 | CA1327750C Therapeutic use of serotonin-antagonists |
| 03/15/1994 | CA1327746C Method of treating fibrotic disorders |
| 03/12/1994 | CA2105934A1 Cyclic urea derivatives |
| 03/10/1994 | CA2105707A1 Substituted cyclohexane derivatives for the treatment of diseases |
| 03/10/1994 | CA2105693A1 Benzopyran compounds, process for the preparation thereof and pharmaceutical compositions containing them |
| 03/10/1994 | CA2105612A1 Use of low doses of manganese superoxide dismutase (mn-sod) in the treatment of diseases |
| 03/10/1994 | CA2105599A1 Prevention of bone resorption |
| 03/09/1994 | EP0586085A2 Veterinary method for the treatment of ketosis in livestock |
| 03/09/1994 | EP0586020A1 Tetracyclines alone or in combination with NSAID for treating tissue destruction |
| 03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585801A2 Bone-related cadherin-like protein and process for its production |